"/> Invitrogen™ Peptide synthétique RNF216 humain | B-LABO France

Invitrogen™ Peptide synthétique RNF216 humain

Réf. : BL-RE-175765Réf. fabricant : 15206419 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
54476
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q9NWF9
Nom usuel
Human RNF216
Marque
Invitrogen

TRIAD3A Synthetic Peptide, PEP-0197, from Invitrogen.

Activation of NF-κB as a result of Toll-like receptor (TLR) and IL-1 receptor signaling is a major component of innate immune responses. Signals from these receptors are relayed by a number of adapter molecules such as TRIF, TIRAP, and MyD88. Several regulatory mechanisms exist to control TLR signal transduction, including the inhibition of TLR expression and signaling by molecules such as ST2 and SIGIRR. Another mechanism is by the ubi-quitinization of selected TLRs by TRIAD3A, an E3 ubiquitin-protein ligase. TRIAD3A is a RING finger protein that can bind to TLR4 and TLR9, and to a lesser extent TLR3 and TLR5, catalyzing the ubiquitization of these molecules. Overexpression of TRIAD3A promoted the nearly complete degradation of TLR4 and TLR9; this reduction was reflected in the decreased signal-specific activation by ligands specific for these TLRs. Conversely, depletion of TRIAD3A resulted in enhanced TLR activation.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175765
Réf. fabricant15206419
Gene ID (Entrez)54476
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ9NWF9
Nom usuelHuman RNF216
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)RNF216
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.